Biotech Course Correction With Treehill Partners' Ali Pashazadeh

It wouldn't be accurate to say that surgeon-turned-healthcare investment banker and consultant Dr. Ali Pashazadeh traded his scalpels for spreadsheets. In fact, he still wields a scalpel quite frequently, and on this episode of the Business of Biotech podcast, he offers a fantastic reason why. Yes, it's a bit of a departure from our normal routine of biotech founders occupying the guest chair. But, Pashazadeh's no-holds-barred reflections on and analysis of biotech breaking points, drawn from more than 2 decades of troubleshooting broken bipharmaceutical businesses and correcting courses, makes for some great programming. Whether you're a biotech builder in the throes of disruption, or feeling lucky that you've been threading scientific, clinical, capital, and regulatory needles all along, this episode offers a ton of insight from the unwritten textbooks on the business of biotech.

Access this and hundreds of episodes of the Business of Biotech videocast under the Listen & Watch tab at bioprocessonline.com.

Get in touch with guest and topic suggestions: [email protected]

Find Matt Pillar on LinkedIn:   / matthewpillar  

---
#businessofbiotech #biopharma #biotech

Subscribe to the podcast:

Apple - https://podcasts.apple.com/us/podcast...
Spotify - https://open.spotify.com/show/5NhjpDe...
YouTube -    • The Business Of Biotech Podcast